Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07203430
What this trial is testing

Biopsychosocial Factors and Muscle Morphology After a Resistance Exercise

Who this might be right for
Low Back Pain, Chronic
University of Central Florida 22
Testing effectiveness (Phase 2)Ended earlyNCT00265200
What this trial is testing

Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungCarcinoma, Small Cell LungMetastases
University of Louisville 28
Not applicableStudy completedNCT02616211
What this trial is testing

An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors

Who this might be right for
Adenocarcinoma of LungLung NeoplasmCancer of Lung+4 more
Mayo Clinic 15
Not applicableLooking for participantsNCT07601867
What this trial is testing

Effect of Dapagliflozin on Right Ventricular-Pulmonary Artery Coupling After Off-Pump Coronary Atery Bypass Grafting

Who this might be right for
Heart FailureCoronary Arterial Disease
Pyatigorsk City Clinical Hospital Number 1 72
Not applicableStudy completedNCT00341601
What this trial is testing

Multi-Drug Resistant Tuberculosis in Korea

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 777
Not applicableStudy completedNCT02120001
What this trial is testing

Efficacy Study on Silver-coated ETT Cleaned With a Novel Device

Who this might be right for
Ventilator Associated PneumoniaCritically Ill
Massachusetts General Hospital 40
Early research (Phase 1)Study completedNCT02259114
What this trial is testing

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Who this might be right for
NUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Not applicableUnknownNCT02075957
What this trial is testing

Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital, Angers 192
Testing effectiveness (Phase 2)Ended earlyNCT03784599
What this trial is testing

T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
The Netherlands Cancer Institute 28
Not applicableStudy completedNCT01130714
What this trial is testing

Resistance Training in Lung Cancer Patients on Chemotherapy

Who this might be right for
InflammationLung Cancer
East Carolina University 15
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Not applicableStudy completedNCT06760143
What this trial is testing

Antibiotic Prophylaxis in Lung-Transplant Recipients

Who this might be right for
Lung-transplant RecipientsAntibiotic Prophylaxis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Not applicableUnknownNCT03131752
What this trial is testing

Early Pulmonary Rehabilitation in Exacerbated COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
Universidade Federal de Sao Carlos 38
Testing effectiveness (Phase 2)Study completedNCT01900652
What this trial is testing

Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 111
Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241
Not applicableEnded earlyNCT03460015
What this trial is testing

Sevoflurane in Chronic Obstructive Pulmonary Disease Exacerbation

Who this might be right for
COPD ExacerbationInvasive Mechanical Ventilation
University Hospital, Montpellier 16
Large-scale testing (Phase 3)Study completedNCT00621504
What this trial is testing

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

Who this might be right for
Bacterial Pneumonia
Forest Laboratories 606
Not applicableUnknownNCT00483925
What this trial is testing

Cardiovascular Risk Factors and LCH in Adults

Who this might be right for
Histiocytosis, Langerhans-Cell
Laikο General Hospital, Athens
Large-scale testing (Phase 3)Study completedNCT06739382
What this trial is testing

Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center

Who this might be right for
Ventilation Acquired Pneumonia
Beni-Suef University 64
Not applicableStudy completedNCT03470233
What this trial is testing

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Korea Otsuka Pharmaceutical Co., Ltd. 149
Next Page